More Australians have been treated for hepatitis C in the past 12 months than the last decade combined, following the listing of a new generation therapy on the Pharmaceutical Benefits Scheme.
Clinical trials for childhood cancer and studies into pain medicine addiction and teenagers living with OCD are among UNSW projects to receive backing from the NHMRC.
For their work in surface chemistry, HIV/AIDS and memory disruption in dementia, three UNSW researchers have won four prestigious Royal Society of NSW Awards for 2016.
A UNSW research trial to examine if e-cigarettes can help smokers quit and a world-first treatment for teenagers with PTSD and substance abuse are among projects to receive major backing in the latest NHMRC funding round.
On World AIDS Day, UNSW’s Kirby Institute has been awarded a $12 million grant to conduct a clinical trial to improve treatment options for people with HIV who have failed first-line antiretroviral therapy.
As it marks its 30th anniversary, the groundbreaking HIV research of UNSW’s Kirby Institute and its pioneering leader David Cooper has been acknowledged by the prestigious medical journal, The Lancet.
New HIV notifications in the non-Indigenous population have stabilised while rates among Aboriginal and Torres Strait Islander men have doubled over the past five years, according to new research.
Australia is on track to cure more people of hepatitis C in 2016 alone than in the past 20 years, according to a new report from UNSW's Kirby Institute.
New hepatitis C treatments are expensive but Greg Dore and Marianne Martinello argue that facilitating global access to safe, direct-acting antivirals will herald a revolution.
Professor Miles Davenport, Dr Deborah Cromer, Dr Mykola Pinkevych and, Dr David Khouryfrom the Kirby Institute at UNSW are part of a team in the running for the UNSW Eureka Prize for Excellence in Interdisciplinary Scientific Research.
